Form 4: CME Group Counsel Reports Routine Stock Activity

Sentiment:

Insider Transaction Report 17 September 2025 1:49 PM

Jonathan L. Marcus, CME Group's Sr MD General Counsel, reported acquisitions, sales, and tax-related dispositions of company stock.

Summary

Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., reported several transactions involving Common Stock Class A.
On September 15, 2025, Mr. Marcus surrendered 259 shares at $258.83 to fulfill tax withholding obligations upon restricted stock vesting.
Also on September 15, 2025, he acquired 2,464 shares of Common Stock Class A at $258.83.
On September 16, 2025, Mr. Marcus sold 376 shares of Common Stock Class A at $258.96, a transaction executed under a Rule 10b5-1 plan adopted on February 18, 2025.
Additionally, on September 16, 2025, he surrendered 294 shares of Common Stock Class A at $259.83 for tax withholding upon restricted stock vesting.
Following these transactions, Mr. Marcus beneficially owns 8,243 shares of Common Stock Class A directly.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions, including stock vesting, tax withholding, and a pre-planned sale, which are common for executives and do not indicate a significant shift in company outlook or insider sentiment.

Positives

Acquisition of 2,464 shares of Common Stock Class A on September 15, 2025, indicating continued equity ownership.

Negatives

Disposition of 259 shares on September 15, 2025, and 294 shares on September 16, 2025, to cover tax withholding obligations.
Sale of 376 shares on September 16, 2025, pursuant to a Rule 10b5-1 plan.

Future Outlook

Industry Context

Stakeholder Impact

Shareholders: Minimal direct impact as these are routine insider transactions and do not signal a major change in company fundamentals or strategy.
Management: Reflects standard executive compensation practices involving equity awards.

Key Dates

Date	Description
02/18/2025	Date Rule 10b5-1 plan was adopted by Jonathan L. Marcus.
09/15/2025	Date of stock acquisition and tax-related disposition.
09/16/2025	Date of stock sale and tax-related disposition.
09/17/2025	Date the Form 4 was signed and filed.

Recommendation

hold

The Form 4 details routine insider transactions, including the vesting of restricted stock, shares withheld for tax obligations, and a pre-scheduled sale under a 10b5-1 plan. These activities are typical for executives and do not provide new fundamental information that would warrant a change in investment recommendation. The transactions are neutral in their implications for the company's future performance or valuation.

Keywords

CME Group, Jonathan L. Marcus, Form 4, Insider Transaction, Stock Vesting, Rule 10b5-1 Plan, Executive Compensation, Common Stock Class A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.